Home Stocks BNBX Applied DNA Sciences, Inc. (NASDAQ: BNBX) Financial Services · Asset Management
— —
Quote unavailable · The latest market session has not been published.
The Quantellect read. The borrow fee is 50.18%. Descriptive summary of the data on this page, not a recommendation.
Relative valuation Lower multiples than peers P/S 0.2× vs peer median 5.5×
Momentum Oversold RSI (14) 26.3 (overbought above 70, oversold below 30)
Short interest 0.1% of float FINRA settlement Oct 30, 2026
BNBX price chart Price — · As of —
SMA 10 — SMA 20 — SMA 50 — SMA 200 —
Price details unavailable for this range. ×
Chart loads when this section enters view.
Dated chart events require JavaScript on this compact chart. Open the full chart for dated events .
Text price and event history 6M plotted price range (ET) Range 6M First date — Last date — Open — High — Low — Close — Volume — Plotted bars 0
Plotted OHLCV bars No price bars are available for this range.
Event records Event records load after the price chart.
Split-adjusted daily prices · Price as of —
Initial 6M price range summary Range 6M First close — Last close — High — Low — Volume —
Open —
Previous close —
Day range —
52-week range —
Volume —
Average volume (30 calendar days) —
Market cap —
P/E (TTM) —
Forward P/E —
EPS (TTM) —
Dividend yield data unavailable —
Beta (5-year monthly vs SPY) —
Price history BNBX · NASDAQ · USD
Split-adjusted · volume in shares
Price history unavailable Retry
Notable price movement — · Notable price movement not available
Options flow — · Options flow not available
Q Score — /100 —
Latest available: Nov 13, 2026 · updates irregularly
Each axis is a 0 to 100 percentile rank among equities
Not scored: Equity peers
Liquidity Not scored Short Not scored Squeeze Not scored Trend Not scored Momentum Not scored Valuation Not scored Stability Not scored What each one means Liquidity Not scored
Higher scores reflect greater average dollar trading volume and less absolute return per dollar traded over 21 sessions within equity peers.
Short Not scored
Higher scores reflect less short-interest pressure relative to trading volume and the company's own history, and less growth in shares short, within equity peers.
Squeeze Not scored
Higher scores reflect a higher published Squeeze score within equity peers.
Trend Not scored
Higher scores reflect a price nearer its 252-session split-adjusted closing high and positive 63- and 126-session total returns.
Momentum Not scored
Higher scores reflect stronger 63- and 126-session total returns within equity peers.
Valuation Not scored
Higher scores reflect lower positive P/E, P/B, EV/EBITDA and price/sales multiples within equity peers; limited data pulls the score toward neutral.
Stability Not scored
Higher scores reflect lower daily total-return volatility over 63 and 252 sessions within equity peers.
How the Q Score works → Quantellect signals — · Quantellect signals not available
How BNBX compares with its industry Against 219 other US-listed Asset Management stocks
Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%
Strongest pointsLatest-quarter year-over-year sales growth was 98.9%, higher than 97% of 219 peers.Peer median 0.0% · As of Nov 17, 2026 Points of cautionSix-month return was -89.6%, with only 0% of 216 peers reporting a lower value.Peer median −5.1% · As of Nov 15, 2026 Trailing-year return on equity was -439.5%, with only 2% of 214 peers reporting a lower value.Peer median 3.5% · As of Nov 17, 2026 Trailing-year net margin was 0%, with only 16% of 189 peers reporting a lower value.Peer median 8.7% · As of Nov 17, 2026 Valuation Lower multiples than peers
Metric BNBX Peer median
Profitability Profitability metrics are lower than most peers.
Metric BNBX Peer median
Growth Growth metrics are higher than most peers.
Metric BNBX Peer median
Quarterly sales growth, year over year 98.9% 0.0%
Top 10% of peers Higher than 97% of 219 peers
5-year sales growth rate — 5.9%
Not ranked: only 35 of 219 peers report it
Balance sheet Not enough peers report balance sheet metrics for a group comparison.
Metric BNBX Peer median
Current ratio 5.79 4.46
Not ranked: only 19 of 219 peers report it
Debt/equity (total borrowings) — 1.10
Not ranked: only 62 of 219 peers report it
Momentum Returns are lower than most peers.
Metric BNBX Peer median
1-year return — −6.1%
Not ranked: only 211 of 219 peers report it
6-month return −89.6% −5.1%
Lowest of 216 peers Higher than 0% of 216 peers
3-month return −80.2% −8.5%
Lowest of 216 peers Higher than 0% of 216 peers
How to read this The dot marks where BNBX ranks among its peers on each metric, from lowest (left) to highest (right). The tick in the middle marks the peer median.
Green marks a rank in the top 10% of peers, amber the bottom 10%. Valuation and balance-sheet metrics stay neutral because a high rank there is not better or worse.
A metric is ranked only when enough peers report it. Peers exclude this company. Percentages count peers with a strictly lower value; equal values do not count.
Lowest Median Highest
Compared with 219 other US-listed Asset Management stocks · fundamentals as of Nov 1, 2026 · prices as of Nov 12, 2026
Upcoming events — · Upcoming events not available
Analyst consensus — · Analyst consensus not available
Earnings history EPS, last 8 quarters −300.00 −200.00 −100.00 0.00 100.00 Q3 ’24 FY ’24 Q1 ’24 Q2 ’25 Q3 ’25 Q1 ’25 Q2 ’26 Q3 ’26
Estimate Beat Miss Match
Fiscal period Est. Actual Result
Q3 2026 — −$0.57 —
Q2 2026 — −$0.68 —
Q1 2025 — −$2.08 —
Q3 2025 — −$34.00 —
Q2 2025 — −$15.35 —
Q1 2024 −$0.31 −$0.56 —
Annual 2024 — −$1.82 —
Q3 2024 −$262.50 $0.47 —
Smart-money activity In the last 60 days: 0 insider sales and 0 purchases. Last quarter: 0 new 13F positions. No congressional trades in 90 days.
Date Type Who Action Amount Source
All smart-money activity → Company profile BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic
CEO Mr. Clay D. Shorrock Esq., J.D.
Headquarters Stony Brook, NY, United States
Employees 26
IPO date Jul 15, 2003
Sector Financial Services
Industry Asset Management Q Score — /100 —
Latest available: Nov 13, 2026 · updates irregularly
Each axis is a 0 to 100 percentile rank among equities
Not scored: Equity peers
Liquidity Not scored Short Not scored Squeeze Not scored Trend Not scored Momentum Not scored Valuation Not scored Stability Not scored What each one means Liquidity Not scored
Higher scores reflect greater average dollar trading volume and less absolute return per dollar traded over 21 sessions within equity peers.
Short Not scored
Higher scores reflect less short-interest pressure relative to trading volume and the company's own history, and less growth in shares short, within equity peers.
Squeeze Not scored
Higher scores reflect a higher published Squeeze score within equity peers.
Trend Not scored
Higher scores reflect a price nearer its 252-session split-adjusted closing high and positive 63- and 126-session total returns.
Momentum Not scored
Higher scores reflect stronger 63- and 126-session total returns within equity peers.
Valuation Not scored
Higher scores reflect lower positive P/E, P/B, EV/EBITDA and price/sales multiples within equity peers; limited data pulls the score toward neutral.
Stability Not scored
Higher scores reflect lower daily total-return volatility over 63 and 252 sessions within equity peers.
How the Q Score works → Quantellect signals — · Quantellect signals not available
Upcoming events — · Upcoming events not available
Analyst consensus — · Analyst consensus not available
Earnings history EPS, last 8 quarters −300.00 −200.00 −100.00 0.00 100.00 Q3 ’24 FY ’24 Q1 ’24 Q2 ’25 Q3 ’25 Q1 ’25 Q2 ’26 Q3 ’26
Estimate Beat Miss Match
Fiscal period Est. Actual Result
Q3 2026 — −$0.57 —
Q2 2026 — −$0.68 —
Q1 2025 — −$2.08 —
Q3 2025 — −$34.00 —
Q2 2025 — −$15.35 —
Q1 2024 −$0.31 −$0.56 —
Annual 2024 — −$1.82 —
Q3 2024 −$262.50 $0.47 —
Company profile BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic
CEO Mr. Clay D. Shorrock Esq., J.D.
Headquarters Stony Brook, NY, United States
Employees 26
IPO date Jul 15, 2003
Sector Financial Services
Industry Asset Management